- Pfizer (New York, NY)
- …trial(s) in support of the development strategy for programs within the Late -Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for ... similar role in industry/CRO + Clinical Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and with a track record of… more
- AbbVie (Jersey City, NJ)
- …Tok (https://www.tiktok.com/@abbvie) . Job Description The Product Safety Team (PST) lead for late stage oncology products, under the direction of the Group Lead ... people's lives across several key therapeutic areas - immunology, oncology , neuroscience, and eye care - and products and...the development medical lead, setting the strategy for the oncology programs. PST lead will be responsible to one… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …for Oncology ** will own the strategy and execution of complex early through late -phase oncology imaging in clinical trials where imaging plays a key role. ... the scientific imaging aspects as well as tumor response assessment of oncology clinical studies in partnership with clinical sciences and preclinical research… more
- Pfizer (New York, NY)
- …+ Medical degree with 5+ years of industry experience + Clinical oncology experience (typically 4+ years) **Preferred Qualifications** Board certified/eligible in ... oncology or equivalent preferred Breast Oncology experience (2+ years) **Organizational Relationships** Reports to Global Development Lead and partners closely… more
- Bristol Myers Squibb (Madison, NJ)
- …a robust enterprise level strategy for asset(s) and indication(s) including early, late and post-marketing development, as well as awareness of the enterprise ... through proof of concept trials and will to assure a seamless transition into late stage development (Phase II-III trials) + Ability to lead and develop a group… more
- Bristol Myers Squibb (Madison, NJ)
- …They will be foundational in working with teams in Research, Early and Late Development, providing insights into biology, translational elements, as well as overall ... indications (lupus, scleroderma, myositis, rheumatoid arthritis) * Work closely with hematology/ oncology physicians to coordinate CAR-T cell therapy treatment in the… more
- Sumitomo Pharma (New York, NY)
- …Europe (Sumitomo Pharma Switzerland GmbH) focused on addressing patient needs in oncology , urology, women's health, rare diseases, psychiatry & neurology, and cell & ... and Europe, and a diverse pipeline of early- to late -stage assets, we aim to accelerate discovery, research, and...Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene… more
- Bayer (Whippany, NJ)
- …development phases from Phase 1 to Phase 3, with an emphasis on late -phase development. You will focus on the purposeful generation of clinical evidence supporting ... early development stage assets (eg, Translational Sciences) and relevant late -stage capabilities, establishing value for radiotracers as standalone diagnostics or… more
- Bristol Myers Squibb (Madison, NJ)
- …proof of concept trials and will assure a seamless transition into late stage development (Phase II-III trials.) **Governance Participation and Signature Authority** ... since this position has responsibility for strategy and clinical research in oncology in multiple geographies + Experience interacting with business development and… more
- Cardinal Health (East Rutherford, NJ)
- …be flexible to work different days, schedules, hours, come in early, stay late , or work overtime based on business needs. **What does Nuclear Pharmacy contribute ... the prompt and accurate delivery and distribution of radiopharmaceuticals or oncology pharmaceuticals to medical care providers in accordance with customer demand… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . TPA is rapidly expanding its operations across all functional areas. TPA's commitment ... to patients and their communities continues with a robust late -stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing… more
- Teva Pharmaceuticals (Parsippany, NJ)
- …our core therapeutic areas which include neuroscience, immunology, and immuno- oncology . We are continually developing patient-centric solutions and significantly ... of our presence across early-stage drug discovery and mid- to late -stage development, particularly in target identification, evaluation, and screening technologies.… more